Involvement of PPAR nuclear receptors in tissue injury and wound repair
- 1 March 2006
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (3) , 598-606
- https://doi.org/10.1172/jci27958
Abstract
Tissue damage resulting from chemical, mechanical, and biological injury, or from interrupted blood flow and reperfusion, is often life threatening. The subsequent tissue response involves an intricate series of events including inflammation, oxidative stress, immune cell recruitment, and cell survival, proliferation, migration, and differentiation. In addition, fibrotic repair characterized by myofibroblast transdifferentiation and the deposition of ECM proteins is activated. Failure to initiate, maintain, or stop this repair program has dramatic consequences, such as cell death and associated tissue necrosis or carcinogenesis. In this sense, inflammation and oxidative stress, which are beneficial defense processes, can become harmful if they do not resolve in time. This repair program is largely based on rapid and specific changes in gene expression controlled by transcription factors that sense injury. PPARs are such factors and are activated by lipid mediators produced after wounding. Here we highlight advances in our understanding of PPAR action during tissue repair and discuss the potential for these nuclear receptors as therapeutic targets for tissue injury.Keywords
This publication has 110 references indexed in Scilit:
- The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosisApoptosis, 2005
- A Peroxisome Proliferator-Activated Receptor-γ Agonist Reduces Infarct Size in Transient but Not in Permanent IschemiaStroke, 2005
- Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responsesKidney International, 2004
- Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathyAmerican Heart Journal, 2003
- Peroxisome Proliferator-Activated Receptor-α and Receptor-γ Activators Prevent Cardiac Fibrosis in Mineralocorticoid-Dependent HypertensionHypertension, 2003
- Leptin Induces Endothelial Cell Migration Through Akt, Which Is Inhibited by PPARγ-LigandsHypertension, 2002
- Peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) activation suppresses ischemic induction of Egr‐1 and its inflammatory gene targetsThe FASEB Journal, 2002
- Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null miceHepatology, 2002
- Regulation of Gene Expression by Activation of the Peroxisome Proliferator-Activated Receptor γ with Rosiglitazone (BRL 49653) in Human AdipocytesBiochemical and Biophysical Research Communications, 1999
- INTESTINAL (MESENTERIC) VASCULOPATHY II: Ischemic Colitis and Chronic Mesenteric IschemiaGastroenterology Clinics of North America, 1998